Clinical TrialsSearch results
Number of results: 1050
Other
- Japan Diabetes Outcome Intervention Trial 2 (J-DOIT2) The large trial to improve the medical care of the family doctors for type 2 diabetes patients and to decrease dropout rate of these patients.
- Type 2 Diabetes Mellitus
- Japan Foundation for the Promotion of International Medical Research Cooperation
- 2009-07-13
Other
- Japan Diabetes Outcome Intervention Trial 2 (J-DOIT2) Pilot research about efficiency of a system supporting type 2 diabetes mellitus medical care by a family doctor
- Type 2 Diabetes Mellitus
- Japan Foundation for the Promotion of International Medical Research Cooperation
- 2006-09-01
Other
- TOPLEVEL study
- Type 2 Diabetes Mellitus
- Kitakaze Masafumi
- 2019-03-18
Other
- Long-term effects of voglibose on diabetic complication in Japanese patients with type 2 diabetes mellitus: a double-blind, randomized, placebo-controlled clinical trial
- Type 2 diabetes
- Takeda Pharmaceutical Company Limited
- 2008-04-07
Other
- Multicenter clinical trial of pioitazone in type 2 diabetes: impact on expression of soluble receptor for advanced glycation end-products (PioRAGE)
- type 2 diabetes
- PioRAGE research group
- 2009-06-09
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09
Other
- Randomized controlled study for an effect of postprandial monitoring with oral hypoglycemic agent in type 2 diabetic patients
- Type 2 diabetes
- Department of Endocrinology and Metabolism, Osaka University School of Medicine
- 2009-06-10
Not yet recruiting
- Effects of SGLT2 inhibitors on appetite in patients with type 2 diabetes
- type 2 diabetes
- Nin Kazuko
- 2023-03-14
Recruiting
- Osaka Metropolitan Diabetes & Obesity Trial 1
- Type 2 diabetes
- Emoto Masanori
- 2024-05-07
Completed
- A 52-week study comparing the efficacy and safety of once weekly IcoSema and daily insulin glargine 100 units/mL combined with insulin aspart, both treatment arms with or without oral anti-diabetic drugs, in participants with type 2 diabetes inadequately controlled with daily basal insulin. (NN1535-4593:COMBINE 3)
- type 2 diabetes
- Miwa Hirotaka
- 2021-11-27